Overactive Bladder in Patients with Prostate Gland Diseases
Keywords:
overactive bladder, prostate gland, benign prostatic hyperplasiaAbstract
The article presents the results of treatment of patients with overactive bladder in combination with various diseases of the prostate gland. The effectiveness of using muscarinic receptor antagonists to reduce the frequency of urgency episodes and increase bladder capacity in patients with prostate diseases is noted.
References
Anger JT, Goldman HB, Luo X, et al. Patterns of medical management of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in the United States. Neurourol Urodyn. 2018;37(1):213-222.
Tubaro A. Defining overactive bladder: epidemiology and burden of disease. Urology 2004; 64:2–6.
Maserejian NN, Chen S, Chiu GR, et al. Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology 2013; 82:560–564.
Hagovska M, Svihra J Sr, Macko L, et al. The effect of pelvic floor muscle training in men with benign prostatic hyperplasia and overactive bladder. World J Urol. 2024;42(1):287. Published 2024 May 2.
Haylen BT, de Ridder D, Freeman RM et al (2010) An international urogynecological association (IUGA)/international continent society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5-26
D'Ancona C, Haylen B, Oelke M et al (2019) The international continent society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn 38(2):433–477
Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1314
https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/disease-management
